Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B

Chronic infection with hepatitis B virus (HBV) is a major risk factor for the development of hepatocellular carcinoma (HCC). The pathogenesis of HBV-associated HCC involves both viral and host factors. The latter include a functionally inefficient CD8(+) T-cell response that fails to clear the infec...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sitia, Giovanni, Aiolfi, Roberto, Di Lucia, Pietro, Mainetti, Marta, Fiocchi, Amleto, Mingozzi, Francesca, Esposito, Antonio, Ruggeri, Zaverio M., Chisari, Francis V., Iannacone, Matteo, Guidotti, Luca G.
Médium: Artigo
Jazyk:Inglês
Vydáno: National Academy of Sciences 2012
Témata:
PNAS Plus
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3420192/
https://ncbi.nlm.nih.gov/pubmed/22753481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1209182109
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky